PfSPZ Vaccine

WITHDRAWN · PHASE1 · Malaria

Sponsor discontinued development of the investigational vaccine for this protocol and shifted to an alternative investigational product.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.